Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Garnero

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 3, 2004
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trialDouglas C Bauer, Dennis M Black, Patrick Garnero, et al.
Arthritis Research & Therapy|May 19, 2005
Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]Tim D Spector, Philip G Conaghan, J Christopher Buckland-Wright, et al.
Arthritis Research & Therapy|July 28, 2009
Identification of progressors in osteoarthritis by combining biochemical and MRI-based markersErik B Dam, Marco Loog, Claus Christiansen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trialGuillaume Chevrel, Anne-Marie Schott, Elisabeth Fontanges, et al.
Arthritis Research & Therapy|June 10, 2010
The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnoverAnne-Christine Bay-Jensen, Nadine C B Tabassi, Lene V Sondergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United StatesSarah J Glover, Martin Gall, Oliver Schoenborn-Kellenberger, et al.
Bone|July 28, 2019
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis statusLaurent Maïmoun, Fayçal Ben Bouallègue, Anthony Gelis, et al.
Joint Bone Spine|January 31, 2012
Association of serum levels of aggrecan ARGS, NITEGE fragments and radiologic knee osteoarthritis in Tunisian patientsEya Kalai, Afef Bahlous, Nadine Charni, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Comparison of serum and lithium-heparinate plasma for the accurate measurements of endogenous and exogenous morphine concentrationsAlexis Laux-Biehlmann, Nadja Gräfe, Jinane Mouheiche, et al.
Clinical Chemistry|January 24, 2002
Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinolineHubert W Vesper, Laurence M Demers, Richard Eastell, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 3, 2004
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trialDouglas C Bauer, Dennis M Black, Patrick Garnero, et al.
Arthritis Research & Therapy|May 19, 2005
Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]Tim D Spector, Philip G Conaghan, J Christopher Buckland-Wright, et al.
Arthritis Research & Therapy|July 28, 2009
Identification of progressors in osteoarthritis by combining biochemical and MRI-based markersErik B Dam, Marco Loog, Claus Christiansen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2006
Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trialGuillaume Chevrel, Anne-Marie Schott, Elisabeth Fontanges, et al.
Arthritis Research & Therapy|June 10, 2010
The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnoverAnne-Christine Bay-Jensen, Nadine C B Tabassi, Lene V Sondergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United StatesSarah J Glover, Martin Gall, Oliver Schoenborn-Kellenberger, et al.
Bone|July 28, 2019
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis statusLaurent Maïmoun, Fayçal Ben Bouallègue, Anthony Gelis, et al.
Joint Bone Spine|January 31, 2012
Association of serum levels of aggrecan ARGS, NITEGE fragments and radiologic knee osteoarthritis in Tunisian patientsEya Kalai, Afef Bahlous, Nadine Charni, et al.
British Journal of Clinical Pharmacology|February 3, 2012
Comparison of serum and lithium-heparinate plasma for the accurate measurements of endogenous and exogenous morphine concentrationsAlexis Laux-Biehlmann, Nadja Gräfe, Jinane Mouheiche, et al.
Clinical Chemistry|January 24, 2002
Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinolineHubert W Vesper, Laurence M Demers, Richard Eastell, et al.
Pageof 12